Treatment of Feline Diabetes Mellitus: Overview and Therapy

Compendium on Continuing Education for the Practicing Veterinarian

Volumn 22, Issue 5, 2000, Pages 423-438

  Behrend, Ellen N ^a,c   Greco, Deborah S ^b,c  

^a AUBURN UNIVERSITY   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

^c AMER COLL OF VET INT MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0347164838     PISSN: 01931903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Panciera DL, Thomas CB, Eicker SW, et al: Epizootiologic patterns of diabetes mellitus in cats: 333 cases (1980-1986). JAVMA 197:1504-1508, 1990.
2. Nelson RW, Feldman EC, Ford SL, et al: Effect of an orally administered sulfonylurea, glipizide, for treatment of diabetes mellitus in cats. JAVMA 203:821-827, 1993.
3. Feldman EC, Nelson RW, Feldman MS: Intensive 50-week evaluation of glipizide administration in 50 cats with previously untreated diabetes mellitus. JAVMA 210:772-777, 1997.
4. Unger RH, Foster DW: Diabetes mellitus, in Wilson JD, Foster DW (eds): Williams Textbook of Endocrinology, ed 3. Philadelphia, WB Saunders Co, 1992, pp 1255-1334.
5. Porte Jr D: β cells in type II diabetes mellitus. Diabetes 40: 166-180, 1991.
6. Lutz TA, Rand JS: Pathogenesis of feline diabetes mellitus. Vet Clin North Am Small Anim Pract 25:527-552, 1995.
7. Lutz TA, Rand JS: A review of new developments in type 2 diabetes in human beings and cats. Br Vet J 149:527-536, 1993.
8. O'Brien TD, Hayden DW, Johnson KH, et al: High dose intravenous glucose tolerance test and serum insulin and glucagon levels in diabetic and non-diabetic cats: Relationships to insular amyloidosis. Vet Pathol 22:250-261, 1985.
9. Kirk CA, Feldman EC, Nelson RW: Diagnosis of naturally acquired type-I and type-II diabetes mellitus in cats. Am J Vet Res 54:463-467, 1993.
10. Sparkes AH, Adams DT, Cripps PJ: Inter- and intraindividual variability of the response to intravenous glucose tolerance testing in cats. Am J Vet Res 57:1294-1298, 1996.
11. Link KR, Rand JS: Glucose toxicity in cats (Abstr). J Vet Intern Med 10:185, 1996.
12. Goossens M, Nelson RW, Feldman EC, et al: Response to insulin treatment and survival in 104 cats with diabetes mellitus (1985-1995). J Vet Intern Med 12:1-6, 1998.
13. Hall DG, Kelley LC, Gray ML, et al: Lymphocytic inflammation of pancreatic islets in a diabetic cat. J Vet Diagn Invest 9:98-100, 1997.
14. Rand JS: Understanding feline diabetes. Proc 14th ACVIM Forum:82-83, 1996.
15. Nelson RW, Griffey FM, Feldman EC, Ford SL: Transient clinical diabetes mellitus in cats: 10 cases (1989-1991). J Vet Intern Med 13:28-35, 1999.
16. Nelson RW, Lewis LD: Nutritional management of diabetes mellitus. Semin Vet Med Surg 5:178-186, 1990.
17. Ihle SL: Nutritional therapy for diabetes mellitus. Vet Clin North Am Small Anim Pract 25:585-597, 1995.
18. Holste LC, Nelson RW, Feldman EC: Effect of dry, soft moist, and canned dog foods on postprandial blood glucose and insulin concentrations in healthy dogs. Am J Vet Res 50:984-989, 1989.
19. Nelson RW, Himsel CA, Feldman EC, et al: Glucose tolerance and insulin response in normal-weight and obese cats. Am J Vet Res 51:1357-1362, 1990.
20. Biourge V, Nelson RW, Feldman EC: Effect of weight gain and subsequent weight loss on glucose tolerance and insulin response in healthy cats. J Vet Intern Med 11:86-91, 1997.
21. Feldman EC, Nelson RW: Diabetes mellitus, in Canine and Feline Endocrinology and Reproduction. Philadelphia, WB Saunders Co, 1996, pp 339-391.
22. Nelson RW, Scott-Moncrieff C, DeVries S: Dietary insoluble fiber and glycemic control of diabetic cats (Abstr). J Vet Intern Med 8:165, 1994.
23. Rand JS: Pathogenesis of feline diabetes, in Reinhart GA, Carey DP (eds): Iams Nutr Symp Proc:83-95, 1998.
24. Nelson RW, Ihle SL, Lewis LD: Effects of dietary fiber supplementation on glycemic control in dogs with alloxan-induced diabetes mellitus. Am J Vet Res 52:2060-2066, 1991.
25. Zerbe CA: Canine hyperlipemias, in Kirk RW (ed): Current Veterinary Therapy IX. Philadelphia, WB Saunders Co, 1986, pp 1045-1053.
26. Remillard RL, Matz ME, Shell LG: Nutritional management of complicated cases of canine diabetes mellitus. Compend Contin Educ Pract Vet 14(2):176-183, 1992.
27. Dutta SK, Hlasko J: Dietary fiber in pancreatic disease: Effect of high fiber diet on fat malabsorption in pancreatic insufficiency and in vitro study of the interaction of dietary fibers with pancreatic enzymes. Am J Clin Nutr 41:517-525, 1985.
28. Nelson RW: Dietary therapy for diabetes mellitus. Compend Contin Educ Pract Vet 10(12):1387-1392, 1988.
29. Greco DS, Broussard JD, Peterson ME: Insulin therapy. Vet Clin North Am Small Anim Pract 25:677-689, 1995.
30. Scherthaner G: Immunogenicity and allergenic potential of animal and human insulins. Diabetes Care 16:155-165, 1983.
31. Peterson ME: Insulin and insulin syringes, in Kirk RW, Bonagura JD (eds): Kirk's Current Veterinary Therapy XI. Small Anim Practice. Philadelphia, WB Saunders Co, 1992, pp 356-358.
32. Casella SJ, Mongilio MK, Plotnick LP: Accuracy and precision of low-dose insulin administration. Pediatrics 91:1155-1157, 1993.
33. Wallace MS, Peterson ME, Nichols CE: Absorption kinetics of regular, isophane and protamine zinc insulin in normal cats. Domest Anim Endocrinol 7:509-516, 1990.
34. Broussard JD, Peterson ME: Comparison of two Ultralente insulin preparations with protamine zinc insulin in clinically normal cats. Am J Vet Res 55:127-131, 1994.
35. Nelson RW, Feldman EC, DeVries S: Use of Ultralente insulin in cats with diabetes mellitus. JAVMA 200:1828-1829, 1992.
36. Bertoy EH, Nelson RW, Feldman EC: Effect of Lente insulin for treatment of diabetes mellitus in 12 cats. JAVMA 206:1729-1731, 1995.
37. Nelson RW: Diabetes mellitus, in Ettinger SJ, Feldman EC (eds): Textbook of Veterinary Internal Medicine, ed 4. Philadelphia, WB Saunders, 1995, pp 1510-1537.
38. Turner RC, Mairead A, Ward EA: Ultralente based insulin regimens - Clinical applications, advantages and disadvantages. Acta Med Scand 671:75-86, 1983.
39. Turner RC, Holman RR: Optimizing conventional insulin regimens to improve control, in Pickup JC (ed): Brittle Diabetes. Oxford, Blackwell Scientific Publications, 1985, pp 200-213.
40. Service RJ, Rizza RA, Hall LD: Prandial insulin requirements in insulin-dependent diabetics: Effects of size, time of day, and sequence of meals. J Clin Endocrinol Metab 57:931-935, 1995.
41. Wallace MS, Kirk CA: The diagnosis and treatment of insulin dependent and non-insulin dependent diabetes mellitus in the dog and the cat. Probl Vet Med 2:573-590, 1990.
42. Peterson ME: Endocrine diseases, in Sherding RG (ed): The Cat: Diseases and Clinical Management, ed 2. New York, Churchill Livingstone, 1994, pp 1465-1470.
43. Larkins RG: New concepts for treatment of non-insulin-dependent diabetes mellitus. Trends Endocrinol Metab 8:187-191, 1997.
44. Gerich JE: Oral hypoglycemic agents. N Engl J Med 321: 1231-1245, 1989.
45. Melander A, Bitzen PO, Faber O: Sulfonylurea antidiabetic drugs: An update of their clinical pharmacology and rational therapeutic use. Drugs 37:58-72, 1989.
46. Ford SL: NIDDM in the cat: Treatment with the oral hypoglycemic medication, glipizide. Vet Clin North Am Small Anim Pract 25:599-615, 1995.
47. Meyerovitch J, Rotenberg P, Shechter Y: Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus. J Clin Invest 87:1286-1294, 1991.
48. Brichard SM, Pottier AM, Henquin JC: Long term improvement of glucose homeostasis by vanadate in obese hyperinsulinemic fa/fa rats. Endocrinology 125:2510-2516, 1989.
49. Cam MC, Pederson RA, Brownsey RW, et al: Long-term effectiveness of oral vanadyl sulphate in streptozotocin-diabetic rats. Diabetologia 36:218-224, 1993.
50. Plotnick AN, Greco DS, Crans DC: Oral vanadium compounds: Preliminary studies on toxicity in normal cats and hypoglycemic potential in diabetic cats (Abstr). J Vet Intern Med 9:181, 1995.
51. Brichard SM, Bailey CJ, Henquin JC: Marked improvement of glucose homeostasis in diabetic ob/ob mice given oral vanadate. Diabetes 39:326-332, 1990.
52. Yuen VG, Pederson RA, Dai S, et al: Effects of low and high dose administration of bis(maltolato)oxovandium (IV) on fa/fa Zucker rats. Can J Physiol Pharmacol 74:1001-1009, 1996.
53. Greco DS: Treatment of type II diabetes mellitus in cats with oral vanadium (Abstr). Diabetes 46:1289, 1997.
54. Crenshaw KL, Peterson ME, Heeb LA: Serum fructosamine concentration as an index of glycemia in cats with diabetes mellitus and stress hyperglycemia. J Vet Intern Med 10:360-364, 1996.
55. Saltiel AR, Olefsky JM: Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45:1661-1669, 1996.
56. Suter SL, Nolan JJ, Wallace P, et al: Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes Care 15:193-203, 1992.
57. Kumar S, Boulton AJM, Beck-Nielsen H, et al: Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Diabetologia 39:701-709, 1996.
58. Bailey CJ, Turner RC: Metformin. N Engl J Med 334: 574-579, 1996.
59. Kraus MS, Calvert AC, Jacobs GJ, et al: Feline diabetes mellitus: A retrospective mortality study of 55 cats (1982-1994). JAAHA 33:107-111, 1997.